<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="other" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Our Dermatol Online</journal-id>
<journal-title>Our Dermatol Online</journal-title>
<issn pub-type="epub">2081-9390</issn>
<publisher>
<publisher-name>Our Dermatology Online</publisher-name>
<publisher-loc>Poland</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">OURD-9-329</article-id>
<article-id pub-id-type="doi">10.7241/ourd.20183.26</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Clinical Image</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Giant neurofibroma: a localization palpebral</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Jouari</surname>
<given-names>Ouiame El</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
<xref ref-type="corresp" rid="cor1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gallouj</surname>
<given-names>Salim</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zinoune</surname>
<given-names>Safae</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baybay</surname>
<given-names>Hanane</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mernissi</surname>
<given-names>Fatima Zahra</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
</contrib-group>
<aff id="aff1"><italic>Department of Dermatology, Hassan II University Hospital, Fez, Morocco</italic></aff>
<author-notes>
<corresp id="cor1">
<bold>Corresponding author:</bold> Dr. Ouiame EL Jouari, E-mail: <email xlink:href="eljouariouiame@gmail.com">eljouariouiame@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<year>2018</year>
</pub-date>
<volume>9</volume>
<issue>3</issue>
<fpage>329</fpage>
<lpage>330</lpage>
<history>
<date date-type="received"><day>07</day><month>01</month><year>2018</year></date>
<date date-type="accepted"><day>31</day><month>03</month><year>2018</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x000a9; Our Dermatol Online 3</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
</license>
</permissions>
</article-meta>
</front>
<body>
<sec id="sec1-1">
<title/>
<p>A 4-year-old child with asymptomatic upper right eyelid mass, observed by the mother since the age of one year, having progressively increased in size. A physical examination revealed a mass of 4 cm taking the upper right eyelid (<xref ref-type="fig" rid="F1">Fig. 1</xref>), of soft consistency with ptosis (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Moreover, the child presented more than 6 coffee milk spots&#x003E; 5 mm long axis, axillary lentigines without palpable adenopathies (<xref ref-type="fig" rid="F3">Fig. 3</xref>). had confrmed that it was a plexiform neurofibroma associated with a dysplasty of the great right sphenoidal wing. the child was referred to the ophthalmology department for the management of his palpebral neurofibroma.</p>
<fig id="F1">
<label>Figure 1</label>
<caption>
<p>A 4 cm mass involving the upper right eyelid.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-9-329-g001.tif"/>
</fig>
<fig id="F2">
<label>Figure 2</label>
<caption>
<p>Profile view revealing ptosis.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-9-329-g002.tif"/>
</fig>
<fig id="F3">
<label>Figure 3</label>
<caption>
<p>Multiples coffee milk spots &#x003E; 5 mm long axis.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-9-329-g003.tif"/>
</fig>
<p>Neurofibroma is a manifestation of neurofibromatosis type 1 (NF1) or Von Recklinghausen disease, who is an oncogenic condition with an autosomal dominant inheritance pattern [<xref ref-type="bibr" rid="ref1">1</xref>]. His incidence in children with NF1 is less than 10&#x0025;. It is identified within the first few years of life. It follows the distribution of the trigeminal nerve [<xref ref-type="bibr" rid="ref1">1</xref>]. It is manifested by a firm or soft palpebral mass with concomitant eyelid edema and it can lead to a ptosis or strabismus. Plexiform neurofibroma mostly occurs on the trunk and proximal extremities and presents as an occasionally pigmented, bag-like mass [<xref ref-type="bibr" rid="ref2">2</xref>]. It is associated with pigmented spots (coffee coloured) in the skin, commonly seen on the back, abdomen and limbs (caf&#x00E9; au lait spots). Axillary freckling and lisch nodules may be present [<xref ref-type="bibr" rid="ref3">3</xref>]. Magnetic resonance imaging (MRI) of the brain and orbits is needed to confirm diagnosis and to define its extent. The treatment is mainly surgical, it must be practiced early in order to avoid intraorbital extension and esthetic damage in children.</p>
</sec>
<sec id="sec1-2">
<title>CONSENT</title>
<p>The examination of the patient was conducted according to the Declaration of Helsinki principles.</p>
</sec>
</body>
<back>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avery</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Katowitz</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Heidary</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Dombi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Packer</surname>
<given-names>RJ</given-names>
</name>
<etal/>
</person-group>
<article-title>Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1:Multidisciplinary Recommendations for Care</article-title>
<source>Ophthalmology</source>
<year>2017</year>
<volume>124</volume>
<fpage>123</fpage>
<lpage>32</lpage>
</nlm-citation>
</ref>
<ref id="ref2">
<label>2</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Meaux</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Calderon</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Solitary Neurofibroma</article-title>
<source>Our Dermatol Online</source>
<year>2015</year>
<volume>6</volume>
<fpage>362</fpage>
<lpage>4</lpage>
</nlm-citation>
</ref>
<ref id="ref3">
<label>3</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cukkemane</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Katheria</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Harinatha</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>An interesting case of neurofibroma of face</article-title>
<source>Our Dermatol Online</source>
<year>2016</year>
<volume>7</volume>
<fpage>479</fpage>
<lpage>81</lpage>
</nlm-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="supported-by">
<p><bold>Source of Support:</bold> Nil</p>
</fn>
<fn fn-type="conflict">
<p><bold>Conflict of Interest:</bold> None declared.</p>
</fn>
</fn-group>
</back>
</article>